JONATHAN G. DRACHMAN

Insider Reports History

Location
Bothell, WA
Signature
/s/ Frank J. Lanza, Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by JONATHAN G. DRACHMAN:

Company Role Class Num Shares Value Price $ Report Date Ownership
Calithera Biosciences, Inc. Director Common Stock 200,000 $77,160 $0.3858 10 Nov 2021 Direct
Neoleukin Therapeutics, Inc. President and CEO, Director Stock Option (Right to Buy) 350,000 02 Aug 2022 Direct
Harpoon Therapeutics, Inc. Director Common Stock 0 11 Mar 2024 Direct
Harpoon Therapeutics, Inc. Director Director Stock Option (Right to Buy) 0 11 Mar 2024 Direct

Insider Reports Filed by JONATHAN G. DRACHMAN

Symbol Company Period Transactions Value $ Form Type Role Filing Time
/report/000095017024029434-drachman-jonathan-g-2024-03-08 Harpoon Therapeutics, Inc. 08 Mar 2024 5 $0 4 Director 11 Mar 2024, 17:19
/report/000120919123056795-drachman-jonathan-g-2023-11-27 Harpoon Therapeutics, Inc. 27 Nov 2023 1 $0 4 Director 28 Nov 2023, 16:25
/report/000120919123039407-drachman-jonathan-g-2023-06-22 Harpoon Therapeutics, Inc. 22 Jun 2023 1 $0 4 Director 23 Jun 2023, 16:32
NGNE Neoleukin Therapeutics, Inc. 02 Aug 2022 1 $0 4 President and CEO, Director 04 Aug 2022, 16:38
/report/000120919122039325-drachman-jonathan-g-2022-06-22 Harpoon Therapeutics, Inc. 22 Jun 2022 1 $0 4 Director 24 Jun 2022, 18:45
NGNE Neoleukin Therapeutics, Inc. 31 Dec 2021 4 $0 5 President and CEO, Director 14 Feb 2022, 18:54
/report/000089924321044150-drachman-jonathan-g-2021-11-10 Calithera Biosciences, Inc. 10 Nov 2021 1 +$171,900 4 Director 10 Nov 2021, 18:31
NGNE Neoleukin Therapeutics, Inc. 24 Aug 2021 3 +$933,550 4 President and CEO, Director 26 Aug 2021, 19:08
NGNE Neoleukin Therapeutics, Inc. 03 Aug 2021 1 $0 4 President and CEO, Director 05 Aug 2021, 16:12
/report/000089924321023541-drachman-jonathan-g-2021-06-11 Calithera Biosciences, Inc. 11 Jun 2021 1 $0 4 Director 14 Jun 2021, 16:05
NGNE Neoleukin Therapeutics, Inc. 03 Jun 2021 2 +$475,354 4 President and CEO, Director 07 Jun 2021, 17:06
/report/000120919121032952-drachman-jonathan-g-2021-05-04-restatement Harpoon Therapeutics, Inc. 04 May 2021 1 $0 4/A Director 14 May 2021, 19:59